Skip to main content
. 2022 Dec 2;13:1048498. doi: 10.3389/fphar.2022.1048498

FIGURE 4.

FIGURE 4

Receiver operating characteristic curve (ROC) analysis of the relationship between drug exposure of ARI(A), DARI(B), ARI plus DARI(C) and clinical efficacy, and the relationship between the dosage of ARI and clinical efficacy (D).